Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation

被引：7

作者：

Imoto, S ^{[1
]}

Murayama, T ^{[1
]}

Gomyo, H ^{[1
]}

Mizuno, I ^{[1
]}

Sugimoto, T ^{[1
]}

Nakagawa, T ^{[1
]}

Koizumi, T ^{[1
]}

机构：

[1] Hyogo Med Ctr Adults, Dept Internal Med, Div Hematol Oncol, Akashi, Hyogo 6738558, Japan

来源：

BONE MARROW TRANSPLANTATION | 2000年 / 26卷 / 07期

关键词：

acute leukemia; allogeneic bone marrow transplantation; relapse; donor lymphocyte infusion; graft-versus-host disease; graft-versus-leukemia effect;

D O I：

10.1038/sj.bmt.1702602

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

A case of acute myelogenous leukemia with a t(8;21) translocation relapsed 5 months after allogeneic bone marrow transplantation (allo-BMT), After chemotherapy-induced hematologic remission, the patient received donor lymphocyte infusions (DLI); 4.9 x 10(8)/kg T cells were infused. After DLI, she achieved molecular CR for the first time after allo-BMT, which lasted for 40 months. However, she suffered from grade III acute GVHD of the skin and the liver. Hepatic GVHD was sustained and resulted in fatal outcome. The case demonstrates that DLI is a double-edged sword. Further study is necessary before DLI can be considered to be a beneficial therapy for acute leukemia.

引用

页码：809 / 810

页数：2

共 50 条

[11] Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? [J].

J Mehta ;

R Powles ;

B Sirohi ;

J Treleaven ;

S Kulkarni ;

R Saso ;

D Tait ;

S Singhal .

Bone Marrow Transplantation, 2002, 29 :853-859

[12] Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia [J].

Azuno, Y ;

Kaneko, T ;

Nishimura, M ;

Okuya, S ;

Nakai, K ;

Nomiyama, J ;

Mori, K ;

Okafuji, K ;

Okubo, M ;

Matsutani, A ;

Kamei, S ;

Zaitsu, Y ;

Takeuchi, Y ;

Oka, Y ;

Kaku, K .

BONE MARROW TRANSPLANTATION, 1996, 18 (01) :257-259

[13] LONG-TERM SIDE-EFFECTS IN CHILDREN RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN FIRST COMPLETE REMISSION OF ACUTE-LEUKEMIA [J].

THURET, I ;

MICHEL, G ;

CARLA, H ;

CHAMBOST, H ;

BLAISE, D ;

DEMEOCQ, F ;

MARANINCHI, D .

BONE MARROW TRANSPLANTATION, 1995, 15 (03) :337-341

[14] A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic Cell Transplantation [J].

Shanavas, Mohamed ;

Messner, Hans A. ;

Kamel-Reid, Suzanne ;

Atenafu, Eshetu G. ;

Gupta, Vikas ;

Kuruvilla, John ;

Kim, Dennis ;

Uhm, Jieun ;

Lambie, Anna ;

Ellis, Laura ;

Lipton, Jeffrey H. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01) :87-92

[15] Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years [J].

Wada, Akinori ;

Kobayashi, Naoki ;

Asanuma, Shinsuke ;

Matsuoka, Satomi ;

Kosugi, Mizuha ;

Fujii, Shiro ;

Noguchi, Shinsuke ;

Miyazono, Takayoshi ;

Nakata, Masanobu ;

Ota, Shuichi ;

Imai, Kiyotoshi ;

Hirano, Teiichi ;

Ogasawara, Masahiro ;

Kiyama, Yoshio ;

Kasai, Masaharu .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) :118-122

[16] Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for β-thalassemia major [J].

Aker, M ;

Kapelushnik, J ;

Pugatsch, T ;

Naparstek, E ;

Ben-Neria, S ;

Yehuda, O ;

Amar, A ;

Nagler, A ;

Slavin, S ;

Or, R .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (02) :145-148

[17] Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years [J].

Akinori Wada ;

Naoki Kobayashi ;

Shinsuke Asanuma ;

Satomi Matsuoka ;

Mizuha Kosugi ;

Shiro Fujii ;

Shinsuke Noguchi ;

Takayoshi Miyazono ;

Masanobu Nakata ;

Shuichi Ota ;

Kiyotoshi Imai ;

Teiichi Hirano ;

Masahiro Ogasawara ;

Yoshio Kiyama ;

Masaharu Kasai .

International Journal of Hematology, 2011, 93 :118-122

[18] Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? [J].

Mehta, J ;

Powles, R ;

Sirohi, B ;

Treleaven, J ;

Kulkarni, S ;

Saso, R ;

Tait, D ;

Singhal, S .

BONE MARROW TRANSPLANTATION, 2002, 29 (10) :853-859

[19] Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor [J].

Chim, C. S. ;

Lie, A. K. W. ;

Liang, R. ;

Au, W. Y. ;

Kwong, Y. L. .

BONE MARROW TRANSPLANTATION, 2007, 40 (04) :339-347

[20] Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor [J].

C S Chim ;

A K W Lie ;

R Liang ;

W Y Au ;

Y L Kwong .

Bone Marrow Transplantation, 2007, 40 :339-347

← 1 2 3 4 5 →